428 results on '"H. Yokozeki"'
Search Results
2. Safety and efficacy of sirolimus gel therapy for patients with TSC involving facial skin lesions in a long-term clinical trial
- Author
-
K Fukai, A Asahina, Y Yoshida, M Ogai, Kazue Yoshida, Yasuyuki Fujita, H Yokozeki, Y Ohno, H Nagai, and Mari Wataya-Kaneda
- Published
- 2019
- Full Text
- View/download PDF
3. Perspiration Research
- Author
-
H. Yokozeki, H. Murota, I. Katayama, H. Yokozeki, H. Murota, and I. Katayama
- Subjects
- Sweating--physiology, Sweat Gland Diseases
- Abstract
Research into perspiration has developed dramatically during the last 15 years, continually improving our understanding of the pathogenesis of sweating disorders. It has become clear that, in addition to its temperature-regulating function, perspiration offers bactericidal protection as well. In this book, select authors further broaden our perspective on perspiration. Contributions cover a variety of new aspects, offering insight into the sweat glands'major role during the onset of disorders such as parapsoriasis, lichen planus, and lichen amyloidosis. They also highlight the importance of Malassezia - an allergen in sweat that exacerbates atopic dermatitis and cholinergic urticarial. Further roles of the sweat glands are discussed, including as storage of stem cells for replenishing epidermal cells in the case of thermal burns or as water retention sites for replenishing moisture in the stratum corneum. In addition, a novel analysis of the sweat glands'three-dimensional structures, using high-speed en-face optical coherence tomography (OCT), is introduced. Offering an in-depth overview of the latest knowledge in perspiration research, this book serves as an essential reference for all medical staff and researchers in the field.
- Published
- 2016
4. CTL differentiation and function (PP-108)
- Author
-
C. Barnard, T. Shimizu, C. Soni, Y. Miyazaki, H. Inagaki, T. Scriba, K. Eshima, A. Baz, T. Otsuki, T. Yoshikawa, D. Hu, S. Liu, G. Christianson, M. Honda, M. Ochoa, U. Mancheño, M. de Kock, J. Chen, S. Hervas-Stubbs, Q. Li, M. Takahashi, A. Soares, M. Tomiyama, T. Sumida, O. Boyman, I. Gonzalez, E. Larrea, W. Hanekom, H. Lee, M. Vallée, H. Kobayashi, M. Mamura, K. Miyake, H. Boom, A. Aranguren, A. Cariou, T. Kawada, H. Kohsaka, K. Takahashi, G. Hussey, L. Wu, J. Yoon, Y. Yamada, S. Ono, Y. Gion, Y. Nishimura, P. Groves, K. Kokubo, H. Hayashi, N. Miyasaka, T. Sproule, S. Shiozawa, M. Kobayashi, D. Roopenian, C. Deng, Y. Guo, M. De Goer de Herve, T. Kitazono, S. Saitoh, Y. Hirata, S. Letourneau, I. Melero, G. Nabel, R. Maekawa, Y. Kang, N. Shinohara, M. Shimizu, D. Douek, A. Kelso, Y. Yamano, Y. Miki, T. Shibata, J. Riezu-Boj, T. Choice, O. Kim, M. Nieda, C. Li, C. Takaku, F. Zapata, H. Suzuki, M. Tomura, N. Kumagai, N. Okiyama, Y. Nakagawa, K. Tsumiyama, S. Olver, S. H. Apte, S. Takaku, D. Margulies, S. Ozaki, G. Kaplan, Y. Taoufik, D. L. Doolan, A. Owaki, K. Sudo, J. Dubrot, K. Kotarsky, D. Price, Y. Kusumoto, B. Oh, H. Park, K. Morimoto, F. Herr, T. Nakatsura, A. Palazon, Z. Fan, N. Kienzle, J. Prieto, S. Chiba, S. Nakae, H. Takahashi, A. A. Karande, S. Ryu, M. Inoue, L. Shi, H. Yokozeki, E. Choi, I. Matumoto, C. Krieg, M. Takahara, M. Maeda, N. Sakemura, H. Okuyama, T. Sugihara, W. W. Agace, and T. Okazaki
- Subjects
CTL ,Immunology ,Immunology and Allergy ,General Medicine ,Function (mathematics) ,Biology ,Cell biology - Published
- 2010
- Full Text
- View/download PDF
5. Close association between metal allergy and nail lichen planus: detection of causative metals in nail lesions
- Author
-
A, Nishizawa, T, Satoh, and H, Yokozeki
- Subjects
Male ,Nail Diseases ,Metals ,Hypersensitivity ,Lichen Planus ,Humans ,Female ,Middle Aged ,Aged ,Retrospective Studies - Abstract
Lichen planus (LP) is a common skin disorder of unknown aetiology that affects the skin, mucous membranes and nails. Although metal allergies have been implicated in the development of oral LP (OLP), the contribution of these allergies to nail LP (NLP) has yet to be studied in detail.To elucidate the link between metal allergy and NLP.We retrospectively analysed 115 LP patients with respect to the contribution of metals to either NLP or OLP. We also attempted to detect the specific metals involved in these nail lesions.Of the 79 patients that received a metal patch test (PT), 24 (30%) were positive for at least one of the metal compounds tested. Notably, the prevalence of positive reactions to metals in the NLP patients was significantly higher as compared with the OLP patients (59% vs. 27%, P0.05). Among the 10 PT-positive patients with NLP, improvement of the skin lesions was seen in six of the patients after removal of dental materials containing causative metals or systemic disodium cromoglycate therapy. On the other hand, only 3 of 16 PT-positive patients with OLP exhibited improvement after the removal of dental materials. Causative metals in the dental fillings/braces were detected in the involved nail tissues.This study suggests that metal allergies are more closely associated with NLP vs. OLP, and that deposited metals in the nail apparatus contribute to the development of lichenoid tissue reactions in the nail bed and matrix.
- Published
- 2012
6. Congenital insensitivity to pain with anhidrosis: a case with preserved itch sensation to histamine and partial pain sensation
- Author
-
T, Tanaka, T, Satoh, A, Tanaka, and H, Yokozeki
- Subjects
Histamine Agonists ,Male ,Rare Diseases ,Pruritus ,Mutation ,Humans ,Pain Perception ,Hereditary Sensory and Autonomic Neuropathies ,Receptor, trkA ,Child ,Histamine - Abstract
Congenital insensitivity to pain with anhidrosis is a rare autosomal recessive hereditary disorder that is characterized by having both sensory neuropathy and anhidrosis. A 6-year-old Japanese boy presented with recurrent fever, lack of sweating, occult bone fractures and impaired pain sensation without mental retardation. Genetic analyses revealed compound heterozygous mutations in the NTRK1 gene that encodes TrkA, which is a receptor for nerve growth factor. While there were no apparent changes in the patient's dermal eccrine glands, the quantitative sudomotor axon reflex test with acetylcholine chloride revealed a complete loss of both the axon reflex-mediated and the directly activated sweat responses. On the other hand, the histamine prick test induced a normal weal response surrounded by a flare phenomenon. Notably, the patient felt both an itch sensation after histamine and a burning sensation after topical capsaicin application. Consistent with these findings, PGP9.5+ nerve fibre innervation of the papillary dermis was observed, although the fibres were completely absent around the eccrine glands. These findings suggest that there was a partial preservation of the nerve endings that express the H(1) receptor and/or TRPV1 in the upper dermis, even though there were mutations of the NTRK1 gene in this case.
- Published
- 2011
7. Basophil recruitment and activation in inflammatory skin diseases
- Author
-
Y, Ito, T, Satoh, K, Takayama, C, Miyagishi, A F, Walls, and H, Yokozeki
- Subjects
Inflammation ,Cell Movement ,Phosphoric Diester Hydrolases ,Humans ,Cell Count ,Pyrophosphatases ,Immunohistochemistry ,Skin Diseases ,Basophils - Abstract
Basophils are blood leukocytes constituting less than 1% of leukocytes. They share morphological and functional similarities with mast cells, but recent studies indicate that basophils play non-redundant roles via the release of several cytokines and lipid mediators, as well as functioning as antigen presenting cells. However, basophil infiltration into the tissues in human skin diseases remains to be addressed.The infiltration of basophils in 24 skin diseases (136 samples) was immunohistochemically analyzed using basophil-specific BB1 antibody. In addition, activation of blood basophils was examined by assessing CD203c expression with flow cytometry.Basophils were detected in skin lesions of atopic dermatitis, prurigo, urticaria, bullous pemphigoid, drug eruptions, eosinophilic pustular folliculitis, insect bites, scabies, Henoch-Schönlein purpura and dermatomyositis. While cell densities in urticaria, bullous pemphigoid and eosinophilic pustular folliculitis were prominent, much lower numbers of basophils were seen in lesional skin of atopic dermatitis. Basophils were entirely absent in psoriasis vulgaris, mastocytosis, tumoral lesions, systemic sclerosis, and systemic lupus erythematosus. Levels of CD203c expression on blood basophils from prurigo and urticaria patients were higher than those from healthy donors.Basophils infiltrate into skin lesions more commonly than previously thought, and thus they may play important roles in a variety of inflammatory skin diseases.
- Published
- 2011
8. Gene silencing of STAT6 with siRNA ameliorates contact hypersensitivity and allergic rhinitis
- Author
-
K, Hosoya, T, Satoh, Y, Yamamoto, K, Saeki, K, Igawa, M, Okano, T, Moriya, O, Imamura, Y, Nemoto, and H, Yokozeki
- Subjects
Chemokine CCL11 ,Mice, Inbred BALB C ,Base Sequence ,Tumor Necrosis Factor-alpha ,Molecular Sequence Data ,Fibroblasts ,Dermatitis, Contact ,Lipids ,Disease Models, Animal ,Mice ,Th2 Cells ,Treatment Outcome ,Hypersensitivity ,NIH 3T3 Cells ,Animals ,Humans ,Gene Silencing ,Interleukin-4 ,RNA, Small Interfering ,STAT6 Transcription Factor ,Rhinitis - Abstract
Silencing of genes using small interfering RNA (siRNA) is a recently developed strategy to regulate the synthesis of target molecules. Signal transducer and activator of transcription 6 (STAT6) is a nuclear transcription factor that mediates Th2-type immunity.To elucidate the therapeutic potential of using siRNA to inhibit STAT6 in allergic reactions, we determined the nucleotide sequences of siRNA specific for STAT6.The selected sequences of STAT6 siRNA specifically inhibited the generation of STAT6 synthesis in dermal fibroblasts and eotaxin (CCL11) production in response to IL-4/TNF-α in vitro. Local administration of STAT6 siRNA in vivo alleviated contact hypersensitivity responses to chemical haptens. This was accompanied by reduced local production of IL-4, IL-13, eotaxin (CCL11), TARC (CCL17) and MDC (CCL22). Similarly, consecutive intranasal instillation of STAT6 siRNA markedly inhibited inflammatory cellular infiltration of mucosal tissues in allergic rhinitis responses in association with reduced IL-4 and IL-5 production from regional lymph node cells. Immediate responses, such as sneezing and nasal rubbing behaviors, were also improved by STAT6 siRNA.Local administration of STAT6 siRNA is thus a promising therapeutic strategy for both Th2-mediated cutaneous diseases and allergic rhinitis.
- Published
- 2010
9. Increased expression of CRTH2 on eosinophils in allergic skin diseases
- Author
-
H, Yahara, T, Satoh, C, Miyagishi, and H, Yokozeki
- Subjects
Adult ,Eosinophils ,Male ,Urticaria ,Case-Control Studies ,Receptors, Prostaglandin ,Humans ,Female ,Prurigo ,Receptors, Immunologic ,Dermatitis, Atopic ,Up-Regulation - Published
- 2009
10. Cysteine proteinase inhibitor in eccrine sweat is derived from sweat gland
- Author
-
T. Hibino, Kenzo Sato, H. Yokozeki, and T. Takemura
- Subjects
Male ,Immunodiffusion ,Physiology ,Cysteine Proteinase Inhibitors ,Eccrine Glands ,Aminopeptidase ,SWEAT ,chemistry.chemical_compound ,Physiology (medical) ,Sweat gland ,medicine ,Humans ,Protease Inhibitors ,Tissue Distribution ,Sweat ,Methacholine Chloride ,Cathepsin ,integumentary system ,Molecular mass ,Chemistry ,Temperature ,Hydrogen-Ion Concentration ,Immunohistochemistry ,Molecular Weight ,Kinetics ,Papain ,medicine.anatomical_structure ,Biochemistry ,Cysteine - Abstract
Although cysteine proteinases have been reported to be present in human eccrine sweat, their endogenous inhibitors, cysteine proteinase inhibitors (CPIs), have remained unstudied. We now present evidence that CPIs are indeed a true ingredient of human eccrine sweat. Sweat induced in sauna was collected over a Vaseline barrier placed on the skin to minimize epidermal contamination. The absence of major epidermal contamination of the sweat was further ensured by monitoring an epidermal marker, high-molecular-mass aminopeptidase. Sweat CPI was purified sequentially by chromatography with Sephacryl S-200, carboxymethylated papain-Sepharose, and anion-exchange Mono Q fast-protein liquid chromatography columns. Sweat CPI has a molecular mass of approximately 15 kDa, is stable for temperature (up to 80 degrees C) and pH (from 3 to 10), and inhibits papain, ficin, and sweat cathepsin B- and H-like enzymes. Sweat CPI may be of sweat gland origin because 1) the rate of CPI output in sweat (CPI concentration x sweat rate) is constant over 45 min; 2) antibody against epidermal CPI, which cross-reacts with sweat CPI, localized immunoreactivity in the sweat duct; 3) CPI activity was present in the glandular extracts of control and methacholine-stimulated (for 1 h in vitro) human sweat glands; and 4) the peaks of CPI activity in the glandular extract and sweat CPI were both eluted (by high-pressure liquid chromatography) at around 15 kDa. Sweat CPI may be very similar to epidermal CPI (which belongs to the stefin family of CPIs) because of many shared characteristics. The identity and function of sweat CPI remain to be studied.
- Published
- 1991
- Full Text
- View/download PDF
11. Pharmacological responsiveness of dissociated native and cultured eccrine secretory coil cells
- Author
-
K. Sato, H. Yokozeki, F. Sato, and K. Saga
- Subjects
medicine.medical_specialty ,Cell division ,Physiology ,Ductal cells ,Immunocytochemistry ,Eccrine Glands ,Biology ,Bone canaliculus ,Ouabain ,Organ Culture Techniques ,Physiology (medical) ,Internal medicine ,Sweat gland ,Keratin ,medicine ,Animals ,Sweat ,Cells, Cultured ,chemistry.chemical_classification ,Macaca mulatta ,Sweat Glands ,Cell biology ,Glucose ,Endocrinology ,medicine.anatomical_structure ,chemistry ,Cell culture ,Cell Division ,medicine.drug - Abstract
Methacholine (MCh)- and isoproterenol (Iso)-stimulated 14CO2 production was compared between freshly dissociated rhesus sweat secretory coil cells (mainly clear cells) and cultured cells (grown on a collagen-coated plastic plate) derived from native cells. 14CO2 production was enhanced by MCh and by Iso in native coil cells (but not in ductal cells) in a pharmacologically specific and dose-dependent manner. 14CO2 production in subcultured coil cells (19-45 days in culture) was only one-third to one-fifth that of native cells. MCh-stimulated 14CO2 production was inhibited by ouabain and furosemide in both native and cultured coil cells. A decrease in 14CO2 production, of about one-half, was already evident in primary cells cultured for less than 1 wk. The decreased pharmacological responsiveness of the cultured coil cells was seen, although the cultured cells showed the typical epithelioid appearance, abundant mitochondria, the occasional presence of intercellular lacunae resembling intercellular canaliculi, and the persistence of immunoreactive keratin. We conclude that 1) a primary culture of sweat gland cells can be initiated from dissociated cells; 2) cultured sweat secretory coil cells qualitatively, but not quantitatively, retain the pharmacological responsiveness and transport activity of the native cells as determined by 14CO2 production; 3) collagenase-dissociated cells represent an excellent in vitro system for the study of glandular function at the cellular level; and 4) the decrease in pharmacological responsiveness is not simply due to trypsin treatment during harvesting of cultured cells, because that of organ-cultured, intact, secretory coils also declines with time of culture.
- Published
- 1990
- Full Text
- View/download PDF
12. Human epidermal T cells predominantly belong to the lineage expressing alpha/beta T cell receptor
- Author
-
F Koning, J E Coligan, Carolyn A. Foster, Armin Rieger, H Yokozeki, Beatrix Volc-Platzer, Klaus Wolff, K. Rappersberger, and Georg Stingl
- Subjects
Pathology ,medicine.medical_specialty ,T-Lymphocytes ,CD3 ,Immunology ,Population ,Receptors, Antigen, T-Cell ,Human skin ,Biology ,Immunoenzyme Techniques ,Antigens, CD ,medicine ,Humans ,Immunology and Allergy ,education ,Cells, Cultured ,Skin ,education.field_of_study ,integumentary system ,Epidermis (botany) ,Antibodies, Monoclonal ,Articles ,Molecular biology ,Microscopy, Electron ,medicine.anatomical_structure ,biology.protein ,Body region ,Epidermis ,CD5 ,Keratinocyte ,CD8 - Abstract
The epidermis of clinically normal-appearing human skin harbors a phenotypically heterogeneous population of T lymphocytes (TCs), the majority of which are CD2+/CD3+/CD5+ "memory" cells, but in an unactivated state, and express the TCR-alpha/beta. In contrast to murine skin, only a very minor subpopulation of CD3+ cells in the human epidermis bears the TCR-gamma/delta. Epidermal TCs primarily are distributed along the rete ridges in the basal keratinocyte layer and are often in close apposition to Langerhans cells (LCs). These TCs were propagated from epidermal cell suspensions after stimulation with TC activating agents (Con A, rIL-1, rIL-2), then evaluated for phenotypic features and TCR diversity. Similar to the in situ situation, most were CD4-/CD8+/TCR-alpha/beta+. In addition, two cultures contained TCR-gamma/delta+ cells; one of these determined to be an adherent CD4-/CD8+ population. Epidermal TCs were significantly (p less than 0.0001) more abundant in the sole than in the other body regions examined (i.e., 40 vs. 7 CD3+ cells/linear centimeter of epidermis) and seemed to have a particular affinity for the acrosyringial epithelium of eccrine sweat ducts. Moreover, the sole usually contained a greater number of CD8+ relative to CD4+ TCs, whereas the epidermal CD4/CD8 ratio in the trunk and extremities was quite variable, although the trend also was towards a slightly larger percentage of CD8+ cells. Collectively, our data suggest that the volar epidermis has a unique microenvironment which is responsible for both the higher density of TCs, preferentially CD8+, and lower number of LCs. This study has not only provided evidence for significant regional variability in the human epidermal TC population of normal skin, but also strengthens the concept for skin-associated lymphoid tissues (SALT), whereby memory TCs recirculate back to the epidermis and interact with resident antigen-presenting cells (i.e., LC).
- Published
- 1990
- Full Text
- View/download PDF
13. Influence of surface microstructure on the reaction of the active ceramics in vivo
- Author
-
H, Yokozeki, T, Hayashi, T, Nakagawa, H, Kurosawa, K, Shibuya, and K, Ioku
- Abstract
When porosity and macro-pore size differ in the same ceramic, the mode of bone regeneration and the degradation of ceramics in vivo is said to be different. However, the reactions in vivo of ceramics that have a different microstructure with the same porosity and the same macro-pore size, are not so far known. In this study, two kinds of beta-tricalcium phosphate (TCP) that had different microstructures but the same porosity and macro-pore size, were manufactured. These TCP were implanted in the distal femurs of 20 mature male rabbits, and their respective areas of ceramics and of regenerated bone were measured after 4, 12 and 24 wk. In both TCPs, the regenerated bone similarly decreased from 4-24 wk in a different way. The area of ceramics in one of these TCPs significantly decreased gradually throughout the observation period. On the other hand, the other TCP showed no marked decrease during the same period. This suggested a possibility that the difference in micro-structure has a large effect on the reaction of the ceramics in the bone.
- Published
- 2004
14. Acute exanthematous pustular drug eruption induced by mexiletine
- Author
-
K, Sasaki, T, Yamamoto, M, Kishi, H, Yokozeki, and K, Nishioka
- Subjects
Male ,Skin Diseases, Vesiculobullous ,Acute Disease ,Humans ,Arrhythmias, Cardiac ,Mexiletine ,Drug Eruptions ,Exanthema ,Middle Aged ,Anti-Arrhythmia Agents - Abstract
A 56-year-old man developed infiltrated erythemas on the trunk, extremities, and face with marked facial edema, one month after taking mexiletine hydrochloride for his arrhythmia. A number of pustules were also noted on the surface of erythemas on his chest and face. Laboratory examination showed liver dysfunction and hypereosinophilia. The culture from pustules was sterile. Histological examination of the biopsied skin from a pustular lesion revealed a subcorneal abscess, and perivascular infiltration of lymphocytes, mononuclear cells and eosinophils in the upper dermis. The skin lesions and facial edema as well were improved within three weeks by withdrawal of mexiletine hydrochloride. Patch tests with 10% and 20% mexiletine hydrochloride in petrolatum showed positive reaction, however, pustules were not provoked on the tested site. We conclude that pustules, infiltrated erythema and facial edema were the signs of acute exanthematous pustular drug eruption induced by mexiletine hydrochloride.
- Published
- 2001
15. [Allergic contact dermatitis]
- Author
-
H, Yokozeki and K, Nishioka
- Subjects
Drug-Related Side Effects and Adverse Reactions ,T-Lymphocytes ,Anti-Inflammatory Agents ,Cosmetics ,Allergens ,Prognosis ,Diagnosis, Differential ,Metals ,Dermatitis, Allergic Contact ,Histamine H1 Antagonists ,Cytokines ,Humans ,Steroids ,Haptens - Published
- 2001
16. Topical glucocorticoids application induced an augmentation in the expression of IL-1alpha while inhibiting the expression of IL-10 in the epidermis in murine contact hypersensitivity
- Author
-
K, Igawa, H, Yokozeki, Y, Miyazaki, K, Minatohara, T, Satoh, I, Katayama, and K, Nishioka
- Subjects
Mice ,Administration, Topical ,Anti-Inflammatory Agents ,Animals ,Epidermis ,Dermatitis, Contact ,Glucocorticoids ,Interleukin-1 ,Interleukin-10 - Abstract
The repeated application of glucocorticoids (GC) on the skin augmented the inflammatory response of both allergic and irritant contact dermatitis in our studies. In order to further clarify the mechanism of such an augmentation of contact hypersensitivity (CHS), we investigated the modulatory effects of cytokines in the epidermis after the administration of GC at challenged sites in CHS. Diflucortolone valerate was applied to BALB/c mice on alternate days for a total of nine times. On day 12, they were contact sensitized with dinitrofluorobenzene (DNFB). Next, on day 17, one day after the last application of GC, they were challenged with DNFB on the ear. The whole challenged ear lobes were removed after a hapten challenge and then were analysed by the RT-PCR method or underwent an immunohistochemical analysis. To clarify the modulatory effects of cytokines in vivo, DNFB sensitized mice pre-treated with GC were injected with rIL-10, IL-1 receptor antagonist (ra) and anti-IL-1alpha monoclonal antibody (mAb) and thereafter were challenged with DNFB. A RT-PCR analysis has demonstrated IL-10 mRNA to be detected in the challenged skin of non-GC-pretreated mice but not in that of GC-pre-treated mice after challenge. On the other hand, the expression of IL-1alpha mRNA in the challenged skin of mice pretreated with GC was more strongly detected that that in mice without GC-pretreatment. Furthermore, an immuno-histochemical analysis in the challenge showed the expression of IL-10 in the skin showed the expression of IL-10 in the challenged epidermis of the non-GC-pretreated mice but not in the GC-pretreated mice and IL-1alpha was also strongly expressed in the epidermis of the GC-pretreated mice. A subcutaneous injection of anti-IL-1alpha mAb or IL-1 ra inhibited the augmented CHS reaction in the GC-pretreated mice. A subcutaneous injection of rIL-10 also inhibited the augmentation of the CHS reaction in the GC-pretreated mice; however, no such inhibition was observed in the non-GC-pretreated mice. These results indicated that both an up-regulation of IL-1alpha production and the inhibition of the IL-10 production in the epidermis at the challenged skin sites in the GC-pretreated mice appear to play a critical role in the GC-induced augmentation of murine CHS.
- Published
- 2001
17. Basophils, eosinophils in allergic responses (WS-043)
- Author
-
K. Yasuda, K. Matsuya, T. Takihara, A. Ishizaka, K. Fukunaga, Y. Kawano, M. Egawa, H. Shitara, K. Tomomatsu, F. Jonsson, R. Takamiya, F. Hosokawa, T. Satoh, M. Nakahira, K. Niimi, D. A. Mancardi, K. Mukai, H. Ogura, S. Tanaka, T. Nabe, K. Ishiwata, N. Mizutani, P. Bruhns, B. Iannascoli, S. Nakae, T. Morishita, T. Oguma, M. Kubo, Y. Minegishi, D. D. Chaplin, C. Taya, N. Kamiishi, K. Oboki, M. Kodama, T. Yoshimoto, T. Wada, K. Sayama, T. Kambayashi, K. Obata, S. Yoshino, H. Yokozeki, J. Miyata, H. Tanaka, H. Karasuyama, K. Nakanishi, M. Sawaguchi, K. Tanaka, M. Fujii, N. Ohmari, K. Asano, N. Watanabe, S. Yoshikawa, K. Saeki, and M. Daeron
- Subjects
Immunology ,Immunology and Allergy ,General Medicine - Published
- 2010
- Full Text
- View/download PDF
18. Multiple minute digitate hyperkeratoses
- Author
-
S, Takagawa, T, Satoh, H, Yokozeki, and K, Nishioka
- Subjects
Family Health ,Humans ,Female ,Keratosis ,Aged ,Pedigree - Abstract
A familial case of multiple minute digitate hyperkeratoses is reported. Hundreds of tiny, spiked, keratotic papules were scattered on the trunk and limbs. Microscopically, the lesions showed digitiform orthohyperkeratosis with tenting of the epidermis. Neither atypical epidermal cells nor a dermal infiltrate were observed. This disease has three types: familial, sporadic and postinflammatory. We have analysed the histopathological features of all the cases reported to date. While the familial and sporadic types are similar, the lesions in the postinflammatory type are composed of parakeratotic columns with an invaginated epidermis. Although morphological analysis may not provide any clues to pathogenetic differences, it seems reasonable to assume that the postinflammatory type is an entity different from the other two forms.
- Published
- 2000
19. Prevention of the initial testosterone surge induced by a luteinizing hormone-releasing hormone analogue in prostate cancer patients: the endocrinological effects of pretreatment with chlormadinone acetate
- Author
-
A, Yamamoto, Y, Sumiyoshi, N, Miyake, H, Yokozeki, H, Kanayama, and S, Kagawa
- Subjects
Male ,Chlormadinone Acetate ,Progesterone Congeners ,Administration, Oral ,Prostatic Neoplasms ,Middle Aged ,Injections ,Gonadotropin-Releasing Hormone ,Treatment Outcome ,Humans ,Drug Interactions ,Drug Therapy, Combination ,Testosterone ,GABA Modulators ,Aged - Abstract
We investigated the endocrinological effects of pretreatment with chlormadinone acetate (CMA) in preventing the initial testosterone surge induced by a luteinizing hormone-releasing hormone (LH-RH) analogue. A total of 25 patients with previously untreated prostate cancer were included in this study. The patients were randomly assigned to 2 treatment groups: Group 1; CMA therapy was begun 4 weeks before the initial LH-RH analogue injection. Group 2; CMA therapy was begun 2 weeks before the initial LH-RH analogue injection. After the initial LH-RH analogue injection, CMA was administered during this study. After LH-RH analogue application, the mean values of serum luteinizing hormone (LH) and testosterone increased in both groups on day 3. However, LH and testosterone levels remained beneath pretreatment values in both groups. The mean relative PSA levels did not significantly increased on day 3 and day 7 in both groups. Our results indicate that pretreatment with CMA for 2 weeks was sufficient to prevent the initial testosterone surge in the maximal androgen blockade which was associated with CMA.
- Published
- 1999
20. Confluent ecchymoses on the lower extremities of a malnourished patient
- Author
-
G, Sasaki, T, Satoh, H, Yokozeki, I, Katayama, and K, Nishioka
- Subjects
Male ,Leg ,Treatment Outcome ,Biopsy, Needle ,Ecchymosis ,Humans ,Avitaminosis ,Vitamins ,Aged - Abstract
Nutritional deficiencies result in many distinctive cutaneous manifestations. Vitamin C deficiency, or scurvy, produces follicular hyperkeratosis, perifollicular hemorrhages, gingival hypertrophy, and bleeding (1). We report here a case of malnutrition who suddenly developed extensive eccymoses on the lower extremities sharing morphological similarities with purpura fulminans. Although the patient did not have the characteristic dermatological features of scurvy, serum levels of vitamins C, K, B12, and E were decreased.
- Published
- 1999
21. [Postoperative prophylactic intravesical instillation of tetrahydropyranyl-adriamycin (THP) for superficial bladder cancer]
- Author
-
H, Kanayama, K, Yokota, Y, Kurokawa, S, Kagawa, H, Yokozeki, T, Inai, I, Ogawa, S, Akazawa, H, Hashimoto, and K, Mizuta
- Subjects
Adult ,Aged, 80 and over ,Male ,Postoperative Care ,Antibiotics, Antineoplastic ,Antibiotic Prophylaxis ,Middle Aged ,Drug Administration Schedule ,Administration, Intravesical ,Urinary Bladder Neoplasms ,Doxorubicin ,Humans ,Female ,Neoplasm Recurrence, Local ,Aged - Abstract
Intravesical instillation of tetrahydropyranyl-adriamycin (THP) was performed on 51 patients with superficial bladder cancer after transurethral resection (TUR) for prophylaxis of recurrence. The instillation was carried out with 20 mg of THP dissolved in 40 ml of distilled normal saline. Instillation was performed once 24 hours postoperatively, 9 times every 2 weeks, and 8 times every 4 weeks. These drugs were instilled for 30 to 60 minutes. The recurrence-free survival at 1, 2 and 3 years was 74.5%, 64.6% and 58.0%, respectively. Side effects of THP instillation were observed in only 4 cases (7.8%) as slight urinary frequency or micturition pain. Cases involving 5 or more tumors, or tumors measuring 3 cm or larger, more frequently demonstrated recurrence. The cases that did not respond to preoperative intravesical instillation of THP demonstrated a high frequency of recurrence. Intravesical instillation of THP as a prophylaxis against recurrence of superficial bladder cancer was effective in selected patients.
- Published
- 1999
22. Subject Index Vol. 217, 2008
- Author
-
Josep Malvehy, F. Berard, Mauro Picardo, Carlo Tomino, Natalija Novak, Eugenia Caggese, Tetsuya Higuchi, Cataldo Patruno, Michiie Sakamoto, G. Safa, Pablo F. Peñas, T.A. Luger, Thomas Bieber, Knut Schäkel, G. Gupta, Daniele Torchia, Thomas Ruzicka, Susana Puig, N. Okiyama, Emilio Pedrosa, Renato G. Panizzon, M. Loppin, Mario Arico, Lucia Gallo, Michael Meurer, Paola Bertuccio, Masayuki Kimoto, Paula Aguilera, Abdul-Ghani Kibbi, Uta Schwanebeck, Carmelo Urso, Anna Balato, Alexander V. Kuznetsov, Rosanna Cuscito, María Jones-Caballero, Mirjana Urosevic, Peter Weisenseel, J. Lamoril, N.H. Shear, Masaru Tanaka, I. Katayama, T. Satoh, Luca Borradori, B. Ben-Said, Ghassan Awar, Fabio Ayala, F.G. Larsen, Joerg C. Prinz, Nicola Balato, Reinhard Dummer, K. Nishioka, Mazen Kurban, Shigeki Inui, L. Tisseau, O. Lejeune, Liliane Chatenoud, J.F. Nicolas, Patrick A. Oberholzer, Carola Berking, Antonio Addis, Hans C. Steinert, Samer Ghosn, Hiroo Yokozeki, Gabriel Salerni, Y. Chaves, Dagmar Wilsmann-Theis, Alberto Giannetti, P. Kidson, Maria Rita Bongiorno, Cristina Carrera, Marlies Wakkee, Giovanni Maria Palleschi, Zenus Saleh, N. Ueda, M. Bourcier, Takahiro Satoh, Xina Grählert, F. Cambazard, Satoshi Itami, Sergio Chimenti, G. Duarte, Anastasia A. Garrido-Ríos, Sonja Molin, Mara Maccarone, H. Yokozeki, Eugenio Torre, T. Simonart, Luigi Naldi, Hitoshi Iyatomi, F. Clonier, Jochen Schmitt, Emmanuel Laffitte, J. Tebib, Tamar Nijsten, Takeshi Nakajima, and H. Kohsaka
- Subjects
Index (economics) ,Statistics ,Subject (documents) ,Dermatology ,Mathematics - Published
- 2008
- Full Text
- View/download PDF
23. [Pretreatment with chlormadinone acetate in prostate cancer patients treated with a luteinizing hormone-releasing hormone analogue]
- Author
-
A, Yamamoto, Y, Sumiyoshi, N, Miyake, H, Yokozeki, H, Kanayama, and S, Kagawa
- Subjects
Gonadotropin-Releasing Hormone ,Male ,Chlormadinone Acetate ,Progesterone Congeners ,Humans ,Prostatic Neoplasms ,Androgen Antagonists ,Testosterone ,Middle Aged ,Drug Administration Schedule ,Aged - Abstract
We evaluated the efficacy of pretreatment with chlormadinone acetate (CMA) in preventing the initial testosterone surge induced by luteinizing hormone-releasing hormone (LH-RH) analogue. A total of 44 patients with previously untreated prostate cancer was included in this study. Patients were randomly assigned to 2 treatment groups: Group I-CMA therapy was begun 4 weeks before the initial LH-RH analogue injection. Group II-CMA therapy was begun 2 weeks before the initial LH-RH analogue injection. After the initial LH-RH analogue injection, CMA was administered for 12 weeks or more. After LH-RH analogue application mean values of serum luteinizing hormone (LH) and testosterone increased in both groups on day 3. However, LH and testosterone levels remained below pretreatment values in both groups. CMA pretreatment reduced the mean serum PSA. The mean relative PSA level slightly increased after administration of the LH-RH analogue in group I on day 7. In group II, the mean relative PSA level decreased after LH-RH analogue administration. Objective response rates at 12 weeks were 83.3% and 93.8% in group I and group II. Our results indicate that pretreatment with CMA for 2 weeks appeared to be sufficient to prevent the initial testosterone surge induced by LH-RH analogue.
- Published
- 1998
24. Experimental study for the development of an in vitro test for contact allergens. 2. Comparison of the in vitro sensitization test with the guinea pig maximization test for contact allergens
- Author
-
M, Arimura, H, Yokozeki, I, Katayama, T, Nakamura, M, Masuda, and K, Nishioka
- Subjects
Hypersensitivity, Immediate ,Mice, Inbred BALB C ,Benzocaine ,Macrophages ,Mitomycin ,T-Lymphocytes ,Guinea Pigs ,Allergens ,Sensitivity and Specificity ,Mice ,Irritants ,Animals ,False Positive Reactions ,Immunization ,Haptens ,Cell Division ,Cells, Cultured ,Spleen - Abstract
We have previously reported an in vitro hapten-specific sensitization method using Pam-212 cells (in vitro sensitization test) to identify the potential effectiveness of contact allergens. In the present study, we conducted comparison studies of 11 allergens and 2 irritants in order to evaluate the method as an alternative predictive test. The guinea pig maximization test (GPMT) was developed based on the test described by Magnusson and Kligman. Our assay was carried out as follows: we treated Pam-212 cells with 13 test chemical solutions, while T cells and macrophages of BALB/c mice were cultured with hapten-conjugated Pam-212 cells for 5 days. After incubation, 10(5) T cells were stimulated with mitomycin-C-treated spleen cells conjugated with chemicals. Three days later, the [3H]methyl thymidine incorporation was counted. The results of the GPMT were in agreement with those reported in previous studies except for benzocaine. In our GPMT experiments, benzocaine was negative, but it had been classified as a moderate sensitizer in previous studies. Our assay detected extreme, strong and moderate sensitizers as previously classified by the GPMT They could be summarized as follows: three of five chemicals classified as moderate sensitizers, and 100% of strong or extreme sensitizers were detected by both the GPMT and the in vitro sensitization test. No irritants showed a positive reaction in our assay. These results support the view that the sensitivity of our in vitro test may be equivalent to that of the GPMT and may be useful as a rapid and objective allergen screening test.
- Published
- 1998
25. Topical vitamin D3 downregulates IgE-mediated murine biphasic cutaneous reactions
- Author
-
I, Katayama, K, Minatohara, H, Yokozeki, and K, Nishioka
- Subjects
Mice, Inbred BALB C ,Dose-Response Relationship, Drug ,Croton Oil ,Administration, Topical ,T-Lymphocytes ,Down-Regulation ,Bone Marrow Cells ,Immunoglobulin E ,Antibodies, Anti-Idiotypic ,Dermatitis, Atopic ,Mice ,Dinitrochlorobenzene ,Animals ,Dinitrofluorobenzene ,Female ,Ear, External ,Haptens ,Cells, Cultured ,Dinitrophenols ,Cholecalciferol - Abstract
Hapten-specific and mast-cell-dependent biphasic (immediate and delayed-onset) cutaneous reactions were induced in a murine model by intravenous injection of anti-DNP IgE antibodies followed by a skin test. Four daily applications of topical 1 alpha,24(OH)2D3 ointment significantly inhibited both the immediate and the delayed-onset cutaneous reactions in a dose-dependent fashion, as well as the croton-oil-induced cutaneous reaction and DNFB contact sensitivity reaction. 1 alpha,24(OH)2D3 itself did not show any sensitizing or irritant potential. The inhibitory effect of 1 alpha,24(OH)2D3 on these reactions was limited to the application site and no systemic effect was observed. Another vitamin D3 analog 1 alpha,25(OH)2D3, also showed an inhibitory effect on IgE-mediated cutaneous reactions. These results suggest that topically applied 1 alpha,24(OH)2D3 might modulate IgE-mediated cutaneous reactions and could thus be useful in the treatment of certain human cutaneous disorders other than psoriasis and related keratinizing disorders.
- Published
- 1996
26. Experimental study for the development of an in vitro test for contact allergens. 1. Primary activation of hapten-specific T cells by hapten-conjugated epidermal cells
- Author
-
H, Yokozeki, I, Katayama, and K, Nishioka
- Subjects
Keratinocytes ,Antigen Presentation ,Macrophages ,T-Lymphocytes ,Immunization, Passive ,Oxazolone ,Chloroquine ,Allergens ,Dermatitis, Contact ,Lymphocyte Activation ,Cell Line ,Epitopes ,Mice ,Trinitrobenzenesulfonic Acid ,Adrenal Cortex Hormones ,Nickel ,Irritants ,Methods ,Animals ,Dinitrofluorobenzene ,Female ,Haptens ,Cell Division - Abstract
We conducted a study on the primary in vitro activation of T cells from non-sensitized mice by using hapten-conjugated Pam 212 cells (keratinocyte cell line). Furthermore, we attempted to develop a simple, quantitative in vitro test to assess the sensitizing potency of contact allergens and applied it to determine the stimulation index (SI) of various chemicals with known degrees of sensitizing potency. Monolayered Pam 212 cells were incubated with a variety of chemicals exhibiting allergenic potential. Washed and fixed T cells depleted of autoreactive T cells and macrophages from spleens of nonsensitized Balb/c mice were cocultured for 5 days with those monolayered Pam cells conjugated with chemicals. They were then harvested and restimulated with mitomycin-C-treated spleen cells conjugated with chemicals in 96-well culture plates to inhibit the proliferation of stimulator cells. We evaluated the sensitizing potency of the following chemicals: oxazolone, TNBS, DNFB and FITC (strong sensitizers); p-phenylendiamine (p-PD), nickel chloride and potassium dichromate (potent sensitizers); betamethasone and budesonide (corticosteroids), and methyl salicylate (MS) as an irritant. T cells sensitized in vitro with TNP-Pam cells and macrophages demonstrated antigen-specific proliferation when restimulated in vitro with mitomycin-C-treated TNP-spleen cells. Subcutaneous injection of these T cells induced contact sensitivity in vivo in an antigen-specific fashion. While T cells cocultured with TNP-3T3 could not be activated even in the presence of macrophages. The SI of strong sensitizers was about 4.00 and that of p-PD was 2.36. The SIs of budesonide, betamethasone and MS were 1.62, 0.98 and 1.21, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1995
27. The relation between osteoporosis of the spine and osteoarthritis of the knee. A study using dual energy X-ray absorptiometry and radiographs
- Author
-
M. Shiraki, M. Igarashi, H. Yokozeki, Takahide Kurokawa, and S. Karube
- Subjects
musculoskeletal diseases ,medicine.medical_specialty ,Bone disease ,Knee Joint ,Radiography ,Osteoporosis ,Osteoarthritis ,Severity of Illness Index ,Absorptiometry, Photon ,Bone Density ,medicine ,Humans ,Orthopedics and Sports Medicine ,Radionuclide Imaging ,Rachis ,Dual-energy X-ray absorptiometry ,Osteoporosis, Postmenopausal ,Aged ,Orthodontics ,Bone mineral ,Aged, 80 and over ,medicine.diagnostic_test ,business.industry ,Middle Aged ,musculoskeletal system ,medicine.disease ,Case-Control Studies ,Orthopedic surgery ,Surgery ,Female ,Spinal Diseases ,Radiology ,business - Abstract
We investigated the relation between osteoporosis of the spine and osteoarthritis of the knee using dual energy X-ray absorptiometry of the lumbar spine to measure bone mineral density and radiographs of the knee in 82 randomly selected females (mean age 77.5 years). Radiographs of the knee were divided into a normal and severe group. The bone mineral density of the severe group was significantly more than that of the normal group.
- Published
- 1995
28. Preparation and characterization of porous apatite ceramics coated with beta-tricalcium phosphate
- Author
-
K, Ioku, K, Yanagisawa, N, Yamasaki, H, Kurosawa, K, Shibuya, and H, Yokozeki
- Subjects
Calcium Phosphates ,Ceramics ,Hot Temperature ,Prostheses and Implants ,Phosphates ,Durapatite ,X-Ray Diffraction ,Osseointegration ,Tensile Strength ,Materials Testing ,Microscopy, Electron, Scanning ,Animals ,Humans ,Rabbits ,Porosity - Abstract
Hydroxyapatite (Ca10(PO4)6(OH)2; HA) is one of the most biocompatible materials with bones, and porous HA is promising bone substitute materials for clinical applications. While there are reports that beta-tricalcium phosphate (Ca3(PO4)2; TCP) has higher resorbability than HA when the material is implanted in a bone defect. In the present study, porous HA coated with beta-TCP was prepared by our unique method. The porous HA of about 60% porosity with interconnecting pore structure was soaked in diammonium hydrogen phosphate solution, and then the HA was sintered at 900 degrees C for 3 h. beta-TCP was revealed by X-ray diffractometry on the surface of porous HA. It was possible to control the content of surface-formed beta-TCP arbitrary by varying the concentration of the solution. The obtained HA coated with 33 wt% beta-TCP (33TCP) had about 60% open porosity with the pore size from 150 to 400 microns. The average compressive strength of this porous ceramics was 17.5 MPa. Surface coated HA with beta-TCP deprived of the brittleness in handling. The weight of HA implanted into muscles was increased obviously at 4 weeks because of formation of carbonate hydroxyapatite on the surface of HA. The weight of 33TCP was scarcely changed up to 12 weeks, but the weight tended to increase at 24 weeks. The carbonate hydroxyapatite was not formed on 33TCP at 4 weeks, but formed on it at 24 weeks. Therefore beta-TCP coated porous HA behaved like beta-TCP initially after implantation, and then behaved like HA.
- Published
- 1993
29. [A case of systemic lupus erythematosus with the central nervous system manifestations (CNS-lupus) mimicking herpes simplex encephalitis (HSE)]
- Author
-
H, Yokozeki, K, Otoyama, I, Katayama, H, Eto, K, Nishioka, S, Nishiyama, R, Hata, and H, Arai
- Subjects
Adult ,Diagnosis, Differential ,Male ,Brain Diseases ,Encephalitis ,Humans ,Lupus Erythematosus, Systemic ,Herpes Simplex - Abstract
A 21-year-old male with SLE developed seizure, loss of consciousness and focal signs referable to involvement of the front-temporal brain regions. MRI (magnetic response imaging) image revealed high signal areas in the temporal lobes. By these findings, herpes simplex encephalitis (HSE) was suspected at first. But neither isolation of herpes simplex virus nor HSV specific IgM by ELISA was detected. Acyclovir administration by intravenous infusion was'nt effective but corticosteroid pulse therapy was effective. The level of anticardiolipin antibody was very high. Finally, the diagnosis of CNS-lupus with HSE-like characteristics was made in this case.
- Published
- 1991
30. In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions
- Author
-
T Kishimoto, Ichiro Katayama, Kiyoshi Nishioka, H. Yokozeki, Toshio Hirano, Yukinori Ohta, Tadao Funato, and Shigeo Nishiyama
- Subjects
Adult ,Pathology ,medicine.medical_specialty ,Receptor expression ,Dermatology ,In situ hybridization ,Psoriasis ,medicine ,Humans ,RNA, Messenger ,Interleukin 6 ,Skin ,Messenger RNA ,biology ,Epidermis (botany) ,Interleukin-6 ,Interleukin ,Nucleic Acid Hybridization ,General Medicine ,DNA ,Middle Aged ,medicine.disease ,Interleukin-6 receptor ,biology.protein ,Interleukin-1 - Abstract
Psoriasis is a disease of abnormal proliferation and differentiation of epidermal cells. Several cytokines released by keratinocytes are implicated as factors responsible for this pathological condition of the epidermis. In order to elucidate the role of these cytokines in psoriasis, messenger RNA (mRNA) expression of interleukin-1 (IL-1) and IL-6 in psoriatic epidermis was investigated using biotin-labelled complementary DNA (cDNA) of the cytokines. Messenger RNA of IL-1 alpha was weakly detected in some normal healthy epidermis specimens and more strongly in all the perilesional uninvolved psoriatic epidermis specimens. It was also expressed in the transitional zone between uninvolved and fully developed psoriatic skin, but was not expressed in lesional skin. In contrast, IL-6 mRNA was rarely expressed in normal healthy epidermis, but was expressed in perilesional uninvolved psoriatic epidermis, in the transitional zone and in the fully developed lesional epidermis, with the maximum intensity in the transitional zone. Expression of mRNA of IL-6 receptor showed a similar tendency to that of IL-6. It was expressed in psoriatic epidermis, most strongly in the transitional zone, but not in normal healthy epidermis. IL-6 was demonstrated immunohistochemically in psoriatic epidermis, but IL-6 receptor was demonstrated only in the transitional zone. Thus IL-6 and its receptor expression correlated well with the formation of psoriatic lesions where IL-1 may initiate their expression. IL-6 may play an important role in the pathogenesis of psoriasis.
- Published
- 1991
31. Acknowledgement to Referees for Dermatology 2008
- Author
-
Pablo F. Peñas, T.A. Luger, María Jones-Caballero, G. Duarte, Emmanuel Laffitte, N. Okiyama, F. Clonier, Anastasia A. Garrido-Ríos, J. Tebib, Carola Berking, N. Ueda, Tamar Nijsten, Thomas Bieber, G. Gupta, Alberto Giannetti, Carmelo Urso, Sonja Molin, M. Bourcier, Samer Ghosn, Rosanna Cuscito, K. Nishioka, Dagmar Wilsmann-Theis, J.F. Nicolas, Takeshi Nakajima, T. Satoh, Satoshi Itami, T. Simonart, Mara Maccarone, H. Yokozeki, Natalija Novak, Maria Rita Bongiorno, Eugenio Torre, Paula Aguilera, Mirjana Urosevic, Cataldo Patruno, Hiroo Yokozeki, Sergio Chimenti, Knut Schäkel, Michiie Sakamoto, Paola Bertuccio, Gabriel Salerni, F. Cambazard, Peter Weisenseel, Y. Chaves, Shigeki Inui, I. Katayama, Luigi Naldi, O. Lejeune, Zenus Saleh, Antonio Addis, Masayuki Kimoto, Hitoshi Iyatomi, Fabio Ayala, Liliane Chatenoud, Jochen Schmitt, Anna Balato, F.G. Larsen, Takahiro Satoh, H. Kohsaka, L. Tisseau, Mazen Kurban, Reinhard Dummer, Uta Schwanebeck, Carlo Tomino, Giovanni Maria Palleschi, Daniele Torchia, Susana Puig, Thomas Ruzicka, Renato G. Panizzon, Alexander V. Kuznetsov, Nicola Balato, P. Kidson, Cristina Carrera, Patrick A. Oberholzer, Marlies Wakkee, Mauro Picardo, Emilio Pedrosa, Mario Arico, Lucia Gallo, Masaru Tanaka, N.H. Shear, Joerg C. Prinz, G. Safa, Abdul-Ghani Kibbi, J. Lamoril, M. Loppin, Xina Grählert, Michael Meurer, Luca Borradori, B. Ben-Said, Ghassan Awar, Hans C. Steinert, Eugenia Caggese, Tetsuya Higuchi, Josep Malvehy, and F. Berard
- Subjects
Medical education ,Acknowledgement ,Dermatology ,Psychology - Published
- 2008
- Full Text
- View/download PDF
32. Dermal Sclerosis in the Lesional Skin of ‘Flagellate’ Erythema (Scratch Dermatitis) Induced by Bleomycin
- Author
-
T. Yamamoto, H. Yokozeki, and K. Nishioka
- Subjects
Flagellate erythema ,Pathology ,medicine.medical_specialty ,business.industry ,Dermatology ,Bleomycin ,medicine.disease ,Scratch dermatitis ,Scleroderma ,chemistry.chemical_compound ,chemistry ,medicine ,business - Published
- 1998
- Full Text
- View/download PDF
33. Acknowledgment to Referees for Dermatology 1998
- Author
-
L. Emtestam, U. Hohenleutner, N. Langenbach, C.W. Lee, Y. Mizukawa, Y. Mitsuhashi, R. Chikama, B. Wanscher, D. Van Neste, P.A. de Viragh, P.E. Kanavaros, M.P. Stefanidou, F. Guerra Rodrigo, D. de Hoop, A.D. Tosca, M. Mock, H.Y. Yang, C. Piérard-Franchimont, S. Kondo, I. van Cromphaut, A. Quiliquini, P.C.M. van de Kerkhof, H. Sugiki, T. Shiohara, T. Ruzicka, H. Iizuka, J.-J. Guilhou, K.S. Stefanaki, T. Suzuki, C. Dickert, F. Baudraz-Rosselet, N. Kawagishi, C. Legume, H. Tagami, C. Letawe, A. Yousefi, W.Ch. Marsch, J. Nilsson, K. Nishioka, A. Miller, D. Parsad, S-C. Kim, E. Svejgaard, Y.K. Tay, B. Hegemann, T. Ishizawa, M.V. Kuipers, K. Miyamoto, H. Yokozeki, R. Akasu, P. Bretschneider, M. Hosokawa, M. Megahed, S. Borelli, R.G. Panizzon, W. Vanscheidt, N. Ohtake, R. Miura, T. Miyazawa, K. Schulte, Y. Hashimoto, G.E. Piérard, S. Ito, Y. Sato, M. Peschen, B. Mevorah, S. Ollmar, K. Wakamatsu, M. Stenström, M. Monod, E. Orion, P. Helmbold, A. Gat, J.J. Hwang, M. Landthaler, S. Brenner, N. Schürer, N. Behnke, C. Hauser, O. Takayama, S. Hogendijk, H. Takahashi, K. Tsukamoto, S. Shimada, P. Filipe, I. Zschocke, J.P. Freitas, J. de Korte, K. Wiek, S. Artik, M. Augustin, J.H. Jung, H. Hashimoto, C. Cipriani, R. Saini, I. Nicander, F.O. Nestlé, K. Tamaki, I. Fumal, R. Nagpal, A. Heremans, R. Bergman, M. Furue, T. Yamamoto, A. Rebora, A.-A. Ramelet, M. Guarrera, C. Avnstorp, and I. Emerit
- Subjects
medicine.medical_specialty ,business.industry ,Family medicine ,medicine ,Dermatology ,business - Published
- 1998
- Full Text
- View/download PDF
34. Thiol-dependent aminopeptidase (350,000 mol wt) as a marker of epidermal contamination in sweat
- Author
-
H. Yokozeki and K. Sato
- Subjects
Adult ,Male ,Hot Temperature ,Physiology ,Cations, Divalent ,Ethylenediaminetetraacetic acid ,Aminopeptidase ,Aminopeptidases ,chemistry.chemical_compound ,Physiology (medical) ,Sweat gland ,Hydrolase ,medicine ,Humans ,Protease Inhibitors ,Sweat ,White petrolatum ,Edetic Acid ,chemistry.chemical_classification ,Chromatography ,integumentary system ,Chemistry ,Fast protein liquid chromatography ,Chromatography, Ion Exchange ,Molecular Weight ,medicine.drug_formulation_ingredient ,Dithiothreitol ,Kinetics ,medicine.anatomical_structure ,Biochemistry ,Epidermal Cells ,Sephadex ,Thiol ,Chromatography, Gel ,Epidermis - Abstract
L-Leucine 2-naphthylamide (Leu-NA) hydrolytic activity is increased 20-fold in eccrine sweat collected by simple scraping (SS) compared with sweat collected over the white petrolatum (Vaseline) barrier (clean sweat, CS) [Am. J. Physiol. 250 (Regulatory Integrative Comp. Physiol. 19): R691-R698, 1986]. Sephadex G-200 chromatography of SS but not that of CS showed a single peak of Leu-NA hydrolytic activity (at pH 8) at 350,000 mol wt. An enzyme with similar molecular weight was eluted from tape-stripped stratum corneum and from stripped skin in situ. Anion-exchange FPLC of the 350,000 fractions yielded a single Leu-NA hydrolase peak at pH 8 (pool IV), which also showed hydrolytic activity for benzoyl-L-arginine-2-naphthylamide (BANA). Both Leu-NA and BANA hydrolytic activities of pool IV were thiol dependent, inhibited by heavy metals, and activated by ethylenediaminetetraacetic acid. The pool IV enzyme also hydrolyzed L-lysine- and L-arginine-2-naphthylamide. The most prominent BANA hydrolase activity was seen in both SS and CS at pH 5.0 at 33,000, which was not associated with Leu-NA hydrolytic activity. Diethylaminoethyl cellulose chromatography of the 33,000 fractions yielded three peaks of BANA hydrolytic activity in SS but only one in CS, suggesting that this thiol-dependent BANA hydrolyzing enzyme in CS may be of sweat gland origin. We conclude that the 350,000 thiol-dependent Leu-NA-hydrolyzing aminopeptidase is one of the most prominent epidermal contaminants and thus is a useful marker of epidermal contamination in sweat samples.
- Published
- 1987
35. Partial purification and characterization of cysteine proteinases in eccrine sweat
- Author
-
Kenzo Sato, H. Yokozeki, and T. Hibino
- Subjects
Iodoacetic acid ,Physiology ,Leupeptins ,Eccrine Glands ,Cathepsin B ,Chromatography, Affinity ,Benzoylarginine-2-Naphthylamide ,Sepharose ,chemistry.chemical_compound ,Leucine ,Physiology (medical) ,Sweat gland ,Endopeptidases ,medicine ,Sweat ,Edetic Acid ,Cathepsin ,biology ,Chemistry ,Chromatofocusing ,Leupeptin ,Hydrogen-Ion Concentration ,Sweat Glands ,Isoenzymes ,Molecular Weight ,Cysteine Endopeptidases ,Dithiothreitol ,medicine.anatomical_structure ,Biochemistry ,Concanavalin A ,biology.protein ,Chromatography, Gel ,Isoelectric Focusing - Abstract
Attempts were made to purify and characterize cysteine proteinases in human eccrine sweat and further clarify their origin. Benzoyl-DL-arginine-beta-naphthylamide (BANA) and L-leucine beta-naphthylamide (LeuNA) hydrolases in thermally induced sweat were sequentially purified by Sephacryl S-200 chromatography and chromatofocusing, which yielded two major peaks of BANA hydrolase activity, BANA-I and BANA-II. Both enzymes are cysteine proteinases as evidenced by stimulation of enzymic activity by dithiothreitol and ethylenediaminetetraacetic acid and its inhibition by iodoacetic acid, (PCMB), and trans-epoxysuccinyl-L-leucylamido-(4-guanidino)-butane (E-64). Unlike BANA-II, BANA-I showed an additional aminopeptidase activity, an affinity to concanavalin A-Sepharose but no affinity to organomercurial sepharose and failed to hydrolyze benzyloxycarbonyl-phenylalanyl-arginine 4-methyl 7-coumarylamide (Z-Phe-Arg-NMec), a specific substrate for cathepsin B, which is poorly sensitive to leupeptin [inhibitor constant (Ki) = 1 X 10(-5) M] and relatively heat resistant. These and other characteristics such as its isoelectric points (PI) (= 5.8) and the Km for Arg-NMec (0.1 mM) and BANA (0.71 mM) all support the possibility that BANA-I is closely related to cathepsin H. In contrast, BANA-II is sensitive to Zn2+, leupeptin (Ki = 5.5 X 10(-9) M), is not adsorbed by concanavalin A- (Con-A)Sepharose, but is bound to organomercurial sepharose. It has a specificity to Z-Phe-Arg-NMec but not to Arg-NMec, has the molecular weight of 27, PI of 5.2, the pH optima for BANA (6.0), and the Km for BANA of 3.3 mM and the Km for Z-Phe-Arg-NMec of 0.1 mM. These features resemble those of liver cathepsin B. Leupeptin-sensitive BANA hydrolase was observed in the glandular extract of isolated sweat glands, which was increased after stimulation with methacholine and isoproterenol in vitro. The data are consistent with the notion that cathepsins B- and H-like enzymes are present in eccrine sweat and the former may be derived from the sweat gland.
- Published
- 1987
36. Origin of periodic acid-Schiff-reactive glycoprotein in human eccrine sweat
- Author
-
H. Yokozeki, S. Yanagawa, and K. Sato
- Subjects
Adult ,Male ,Physiology ,Sweating ,Periodic acid–Schiff stain ,Biology ,Eccrine Glands ,Physiology (medical) ,medicine ,Humans ,Sweat ,Polyacrylamide gel electrophoresis ,Glycoproteins ,Skin ,chemistry.chemical_classification ,Gel electrophoresis ,Antiserum ,Chromatography ,Histocytochemistry ,Periodic Acid-Schiff Reaction ,Molecular biology ,Blood proteins ,Sweat Glands ,Immunodiffusion ,medicine.anatomical_structure ,chemistry ,Dark cell ,Electrophoresis, Polyacrylamide Gel ,Glycoprotein - Abstract
To evaluate the possible involvement of ductal blockade with periodic acid-Schiff (PAS)-positive materials in the mechanism of hidromeiosis in humans, skin slices were incubated with methacholine for 2 h and PAS-positive materials localized histologically in the ductal lumen. In 20% of the glands complete ductal blockade with PAS-positive materials was noted. The characteristics and origin of such PAS-positive glycoproteins in human sweat were then studied using various electrophoretic techniques. One-dimensional sodium dodecylsulfate-polyacrylamide gel electrophoresis (1-D SDS-PAGE) demonstrated considerable individual variation in the electrophoretic pattern; however, four major bands at 45, 28, 20, and 18K shared by different individuals, were PAS positive. Further studies using two-dimensional SDS-PAGE, immunodiffusion and immunoaffinity chromatography demonstrated that the PAS-positive glycoproteins are not derived directly from serum because they are electrophoretically and antigenically distinct from serum proteins, including alpha 1-glycoprotein, alpha 2-HS-glycoprotein, and alpha 1-antitrypsin. Since only dark cell granules are densely stained in the histochemical PAS staining, and because antiserum produced against the PAS-positive band selectively stained cells facing the secretory coil lumen (which are most likely dark cells), it is suggested that PAS-positive sweat glycoproteins are derived predominantly from the dark cells.
- Published
- 1986
37. [A case of intrascrotal rhabdomyosarcoma]
- Author
-
H, Yokozeki, T, Inai, S, Kagawa, and K, Hiraishi
- Subjects
Male ,Rhabdomyosarcoma ,Genital Neoplasms, Male ,Scrotum ,Combined Modality Therapy - Abstract
We report a case of intrascrotal rhabdomyosarcoma. A 15-year-old boy visited our clinic with the chief complaint of swelling of the right hemiscrotum. He had a history of fever and right hemiscrotal pain. With the initial diagnosis of acute epididymitis, the patient underwent medical therapy with antibiotics. One month later, because the mass had not responded to medical therapy, a right inguinal orchiectomy was done. Histologic examination revealed rhabdomyosarcoma. The patient received retroperitoneal lymph node dissection and combined chemotherapy with cyclophosphamide, bleomycin, actinomycin-D, adriamycin and vinblastine. He was well 5 years and 10 months postoperatively with no evidence of tumor recurrence or metastasis.
- Published
- 1987
38. Proteolytic enzymes in human eccrine sweat: a screening study
- Author
-
N. Horie, H. Yokozeki, and K. Sato
- Subjects
Electrophoresis ,Proteases ,medicine.medical_specialty ,Physiology ,medicine.medical_treatment ,Substrate Specificity ,SWEAT ,Physiology (medical) ,Internal medicine ,Sweat gland ,medicine ,Stratum corneum ,Humans ,Protease Inhibitors ,Sweat ,chemistry.chemical_classification ,Protease ,integumentary system ,biology ,Proteolytic enzymes ,Caseins ,Hydrogen-Ion Concentration ,Enzyme assay ,Enzyme ,medicine.anatomical_structure ,Endocrinology ,chemistry ,Biochemistry ,biology.protein ,Gelatin ,Epidermis ,Peptide Hydrolases - Abstract
Thermally induced human eccrine sweat was collected both by simple scraping (SS) and by a polyethylene sweat collector that covered the Vaseline-coated skin of the back to minimize epidermal contamination (CS, clean sweat). Using synthetic chromogenic Kabi S-series substrates, we demonstrated a variety of proteases in both SS and CS, the former being higher than the latter to varying extents. The higher enzyme activity in SS is mainly due to epidermal contamination because abundant protease activity was eluted from the nonperspiring stripped and unstripped skin in vivo and from the stripped stratum corneum itself. The electrophoretic separation of sweat protein has shown that CS contains at least 7 and SS 15 gelatinolytic proteinases. Although some CS proteinases could be derived from the sweat duct, the sweat secretory coil itself is responsible for at least two proteinases at 78 and 25 kilodaltons. The identity and function of these enzymes remain to be studied.
- Published
- 1986
39. [Renal Pelvic Cancer with Inferior Vena Cava Tumor Thrombus: A Case Report].
- Author
-
Yokozeki H, Sumiyoshi T, Yamane T, Hosomi T, Nakagawa H, Igarashi A, Takeda M, Matsuoka T, Murakami K, Kono J, Kita Y, Masui K, Sano T, Goto T, Sawada A, Teramoto Y, and Kobayashi T
- Subjects
- Humans, Male, Aged, Magnetic Resonance Imaging, Tomography, X-Ray Computed, Vena Cava, Inferior pathology, Vena Cava, Inferior diagnostic imaging, Kidney Neoplasms pathology, Kidney Neoplasms diagnostic imaging, Kidney Neoplasms surgery, Kidney Pelvis diagnostic imaging, Kidney Pelvis pathology
- Abstract
A 68-year-old male was referred to our hospital because plain computed tomography (CT) showed right hydronephrosis. Contrast-enhanced CT revealed a mass with an irregular margin and poor contrast effect in the lower pole of the right kidney, which invaded the perirenal fat tissues and the area around the inferior vena cava (IVC). Moreover, a thrombus extending from the right renal vein to the IVC was detected, some of which was suggestive of tumor components on contrast-enhanced magnetic resonance imaging (MRI). Biopsy of the renal pelvic mucosa revealed urothelial carcinoma, which was diagnosed as cT4N0M0 renal pelvic cancer. After five courses of neoadjuvant chemotherapy with gemcitabine plus carboplatin, the patient underwent right nephroureterectomy. To avoid tumor cell dissemination into the abdominal cavity, we removed the thrombus and a portion of the IVC were removed en bloc with the right kidney without opening the vein. On pathological diagnosis, the renal tumor was identified as high-grade urothelial carcinoma with sarcomatoid features and squamous differentiation. The tumor invaded the IVC wall through perirenal fat tissues and further developed into a mass in the lumen of the vein. Although the patient was treated with nivolumab as a postoperative adjuvant therapy, he developed liver metastases and local recurrence on the right psoas muscle 6 months after surgery and is currently receiving chemotherapy with enfortumab vedotin.
- Published
- 2024
- Full Text
- View/download PDF
40. Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged ≥ 13 years.
- Author
-
Yokozeki H, Murota H, Matsumura T, and Komazaki H
- Subjects
- Humans, Double-Blind Method, Female, Male, Middle Aged, Treatment Outcome, Adult, Drug Therapy, Combination methods, Aged, Adolescent, Young Adult, Adrenal Cortex Hormones administration & dosage, Adrenal Cortex Hormones adverse effects, Dose-Response Relationship, Drug, Pruritus drug therapy, Pruritus etiology, Administration, Cutaneous, Administration, Topical, Prurigo drug therapy, Quality of Life, Antibodies, Monoclonal, Humanized administration & dosage, Antibodies, Monoclonal, Humanized adverse effects
- Abstract
Background: Prurigo nodularis (PN), a chronic inflammatory skin condition, adversely affects the quality of life of affected individuals. Current treatment options for PN in Japan are limited., Objectives: To evaluate the optimal dose, efficacy and safety of long-term treatment with nemolizumab in patients with PN in Japan., Methods: In a 16-week double-blind phase II/III study, patients aged ≥ 13 years with PN were randomly assigned (1 : 1 : 1) to nemolizumab 30-mg, 60-mg or placebo groups, with concomitant topical corticosteroids, every 4 weeks. The primary efficacy endpoint was the percentage change in the weekly mean Peak Pruritus Numerical Rating Scale (PP-NRS) score (range 0-10, with higher scores indicating worse itching) from baseline to week 16. Secondary efficacy endpoints assessed the impact of treatment on pruritus, PN severity, sleep and quality of life., Results: At week 16, the least-squares mean percentage change from baseline in the PP-NRS score was -61.1% in the nemolizumab 30-mg group (n = 77), -56.0% in the 60-mg group (n = 76), and -18.6% in the placebo group (n = 76). Differences between both nemolizumab groups and placebo were significant; the difference between the 30-mg and placebo groups was -42.5% [95% confidence interval (CI) -51.9 to -33.1; P < 0.0001], and between the 60-mg and placebo groups was -37.4% (95% CI -46.7 to -28.1; P < 0.0001). Patients treated with nemolizumab also had greater improvements in the number and severity of prurigo nodules, and in sleep and quality of life compared with the placebo group. Both nemolizumab doses were well tolerated., Conclusions: Improvements in PN were greater following nemolizumab treatment, despite continuation of topical corticosteroids in both groups., Competing Interests: Conflicts of interest H.Y. reports receiving grants, honoraria and advisory board fees from Maruho Co. Ltd, and honoraria from Kaken Co. Ltd. H.M. reports receiving grants, honoraria, and consulting and advisory board fees from Maruho Co. Ltd. T.M. and H.K. report being employed by Maruho., (© The Author(s) 2024. Published by Oxford University Press on behalf of British Association of Dermatologists.)
- Published
- 2024
- Full Text
- View/download PDF
41. Cutaneous basophil infiltration in atopic dermatitis is associated with abundant epidermal infiltration of helper T cells: A preliminary retrospective study.
- Author
-
Nagashima N, Ugajin T, Miyake K, Walls AF, Namiki T, Yokozeki H, Karasuyama H, and Okiyama N
- Subjects
- Humans, Basophils, Retrospective Studies, Skin pathology, Epidermis pathology, T-Lymphocytes, Helper-Inducer, Dermatitis, Atopic complications, Dermatitis, Atopic diagnosis, Dermatitis, Atopic drug therapy
- Abstract
Atopic dermatitis (AD) is a heterogenous inflammatory skin disorder. Our previous study revealed that basophil infiltration in skin is observed in approximately 60% of AD cases. However, the clinical and histological characteristics of AD associated with basophil infiltration remain unclear. We examined basophil infiltration by immunohistochemical staining of 38 specimens from 34 patients who underwent skin biopsies to diagnose AD from April 2016 to September 2021 at Tokyo Medical and Dental University Hospital. The patients/specimens were divided into two groups, 17 patients/21 specimens associated with little or no basophil infiltration (basophil-low group) and 17 patients/17 specimens associated with marked basophil infiltration (basophil-high group). The clinical characteristics of the patients (age, sex, complications, blood biomarkers, skin symptoms, and treatment) and histological features of the specimens were compared between the groups. Basophil-high patients were significantly younger than basophil-low patients. Blood basophil counts were higher in basophil-high patients than in basophil-low patients. CD4
+ T-cell infiltration was more marked in basophil-high specimens than in basophil-low specimens. CD4+ T cells infiltrated into the dermis as well as into the epidermis only in the basophil-high specimens. Thus, basophil-high AD can be characterized by skin lesions associated with abundant helper T-cell infiltration in younger patients., (© 2023 Japanese Dermatological Association.)- Published
- 2024
- Full Text
- View/download PDF
42. Activated Akt expression is associated with the recurrence of primary melanomas and further refines the prognostic and predictive values for relapse in acral melanomas.
- Author
-
Nojima K, Hayashi M, Tanemura A, Al-Busani H, Saito T, Suzuki T, Ishikawa M, Mori T, Wada S, Yamazaki N, Katayama I, Mori H, Yokozeki H, Okiyama N, Sasaki Y, and Namiki T
- Subjects
- Humans, Proto-Oncogene Proteins c-akt, Prognosis, Chronic Disease, Recurrence, Protein Serine-Threonine Kinases, Melanoma pathology, Skin Neoplasms genetics, Skin Neoplasms pathology
- Abstract
A PTEN deficiency leads to the activation of phospho-Akt at serine 473 (p-Akt) and promotes the tumorigenesis of melanomas by coupling with NUAK2 amplification. We tested the prognostic impact of p-Akt and/or NUAK2 expression on the relapse-free survival (RFS) and overall survival (OS) of melanoma patients. Primary tumors from patients with acral melanomas (112), Low-cumulative sun damage (CSD) melanomas (38), and High-CSD melanomas (18) were examined using immunohistochemistry and their prognostic significance was analyzed statistically. The expression of p-Akt was found in 32.1%, 68.4%, and 55.6% of acral, Low-CSD, and High-CSD melanomas, while NUAK2 expression was found in 46.4%, 76.3%, and 50.0%, respectively. Either p-Akt or NUAK2 expression was inversely correlated with the RFS of primary melanoma patients and acral melanoma patients (p-Akt: p < .0001, p < .0001; NUAK2; p = .0005, p < .0001, respectively). Strikingly, multivariate analyses revealed that p-Akt had a significant impact on RFS (Hazard ratio = 4.454; p < .0001), while NUAK2 did not. Further subset analyses revealed that p-Akt expression had an inferior RFS of patients with acral melanomas (Hazard ratio = 4.036; p = .0005). We conclude that the expression of p-Akt has a significant impact on RFS of patients with primary melanomas and can predict the relapse of patients with acral melanomas., (© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
43. Long-term evaluation of the safety and efficacy of a novel 20% oxybutynin hydrochloride lotion for primary palmar hyperhidrosis: An open-label extension study.
- Author
-
Fujimoto T, Terahara T, Okawa K, Inakura H, Hirayama Y, and Yokozeki H
- Subjects
- Humans, Adolescent, Treatment Outcome, Double-Blind Method, Mandelic Acids adverse effects, Hyperhidrosis drug therapy
- Abstract
The long-term safety and efficacy of 52-week application of oxybutynin hydrochloride 20% lotion (20% OL) for the treatment of primary palmar hyperhidrosis (PPHH) in Japanese patients aged ≥12 years were evaluated in an open-label extension (OLE) of a 4-week, randomized, double-blind (DB) study. The OLE included 114 patients who completed the DB study and wished to continue treatment and 12 new patients. In the safety analysis population (125 patients), the incidence of adverse events (AEs) and adverse drug reactions (ADRs) was 79.2% and 36.0%, respectively. Serious AEs were observed in two patients but were considered unrelated to the investigational drug. The incidence of AEs that led to study discontinuation was 1.6%. The incidence of application site AEs and ADRs was 35.2% and 26.4%, respectively. The severity of most events was mild. The incidence of anticholinergic AEs related to dry mouth was 3.2% for thirst and 0.8% for dry throat. The long-term efficacy of 20% OL was confirmed by a long-lasting reduction in sweat volume and improvement in the Hyperhidrosis Disease Severity Scale and Dermatology Life Quality Index. This study has several limitations: First the results may include some bias because most of the participants were from the prior DB study; second, the results may not be generalizable because only a few participants were in the age group most susceptible to PPHH (i.e., < 15 years old); and third, the study did not obtain safety information from treatment for more than 52 weeks, so this information must be collected in clinical practice in the future. No reduced therapeutic effect was observed in patients with PPHH in this study after 52-week application of 20% OL. Also, few patients experienced serious AEs or AEs that led to study treatment discontinuation., (© 2023 Japanese Dermatological Association.)
- Published
- 2023
- Full Text
- View/download PDF
44. Pancreatitis as immune-related adverse event during pembrolizumab therapy for multiple lung metastases from renal pelvic cancer.
- Author
-
Kokura K, Watanabe J, Takuma T, Yokozeki H, Uketa S, and Uemura Y
- Abstract
Introduction: Pembrolizumab administration has become the standard of care for patients with urothelial carcinoma, though a variety of adverse events have been reported. Presented here is a rare case of pancreatitis that occurred as an immune-related adverse event., Case Presentation: An 81-year-old man undergoing treatment with pembrolizumab for multiple lung metastases from renal pelvic cancer was presented with a fever and diagnosed with pancreatitis based on elevated pancreatic enzyme levels and imaging findings. There was no history of alcohol consumption or findings indicating gallstones, elevated liver enzymes, or abdominal complications. The patient was diagnosed with immune-related adverse event pancreatitis and treated with Lactate Ringer's solution (3000 mL/day) and steroids, during which his condition improved., Conclusion: Although pancreatitis is a rare complication, it should always be considered as a potential immune-related adverse event in patients treated with an immune checkpoint inhibitor such as pembrolizumab., Competing Interests: The authors declare no conflict of interest., (© 2023 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Urological Association.)
- Published
- 2023
- Full Text
- View/download PDF
45. Efficacy and safety of omalizumab in adult patients with wheat-dependent exercise-induced anaphylaxis: Reduction of in vitro basophil activation and allergic reaction to wheat.
- Author
-
Chinuki Y, Kohno K, Hide M, Hanaoka K, Okabe T, Fukunaga A, Oda Y, Adachi A, Ugajin T, Yokozeki H, Suzuki R, Sugiyama A, Kishikawa R, Yamasaki O, and Morita E
- Subjects
- Adult, Humans, Allergens, Basophils, Exercise, Gliadin, Omalizumab adverse effects, Anaphylaxis drug therapy, Anaphylaxis etiology, Anaphylaxis diagnosis, Exercise-Induced Allergies, Wheat Hypersensitivity drug therapy, Wheat Hypersensitivity diagnosis
- Abstract
Background: In patients with wheat-dependent exercise-induced anaphylaxis (WDEIA), anaphylactic shock occurs frequently, therefore avoidance of wheat products is recommended. We aimed to evaluate efficacy and safety of long-term omalizumab treatment for adult patients with WDEIA., Methods: In this phase 2, multicentre single-arm trial, 20 adult patients with WDEIA were enrolled (UMIN 000019250). All patients were administered 150-600 mg of omalizumab subcutaneously and evaluations (basophil activation and blood examination) were performed at regular intervals during administration period (0-48 weeks) and observation period (48-68 weeks). Primary endpoint was proportion of the patients who achieved a basophil activation rate below 10% with fractionated wheat preparations, and secondary endpoint was proportion of the patients with no allergic reactions after wheat products ingestion., Results: During the omalizumab treatment, more than 80% of the patients achieved the basophil activation rate less than 10% against all fractionated wheat preparations, and 68.8% of the patients who achieved the primary endpoint experienced no allergic reaction. During the observation period, the proportion of the patients who achieved a basophil activation rate below 10% decreased gradually, and the proportion of patients with positive allergic reactions increased gradually thereafter and reached maximum of 46.7%. Severe adverse events were not observed during the study., Conclusions: Long-term omalizumab treatment is safe and effective for adult patients with WDEIA when assessed by basophil activation rate with wheat allergens as well as allergic reactions after lifting of restrictions on wheat intake. However, this is not enough to achieve desensitization., (Copyright © 2023 Japanese Society of Allergology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
46. A novel lotion formulation of 20% oxybutynin hydrochloride for the treatment of primary palmar hyperhidrosis: A randomized, placebo-controlled, double-blind, phase III study.
- Author
-
Fujimoto T, Terahara T, Okawa K, Inakura H, Hirayama Y, and Yokozeki H
- Subjects
- Humans, Treatment Outcome, Sweat, Double-Blind Method, Mandelic Acids adverse effects, Hyperhidrosis diagnosis, Hyperhidrosis drug therapy
- Abstract
Background: No previous controlled studies have been specifically designed or adequately powered to show the efficacy of topical oxybutynin for palmar hyperhidrosis by using quantitative measures., Objective: To evaluate efficacy of 20% oxybutynin hydrochloride lotion (20% OL) in reducing palmar sweat volume in patients with primary palmar hyperhidrosis (PPHH)., Methods: In a randomized controlled trial, Japanese patients with PPHH aged 12 years and older received either 20% OL (n = 144) or placebo (n = 140) on both palms once daily for 4 weeks. Palmar sweat volume was measured by the ventilated capsule method. For the primary outcome, response was defined as a reduction of sweat volume of at least 50% from baseline., Results: At week 4, the responder rate for sweat volume was significantly higher in the 20% OL arm than in the placebo arm (52.8% vs 24.3%, respectively; treatment difference, 28.5% [95% CI, 17.7% to 39.3%]; P < .001). No serious adverse events occurred, and no adverse events led to treatment discontinuation., Limitations: The treatment period was only 4 weeks., Conclusions: In patients with PPHH, 20% OL is superior to placebo in reducing palmar sweat volume., Competing Interests: Conflicts of interest Dr Yokozeki and Dr Fujimoto received medical consultant fees from Hisamitsu Pharmaceutical Co, Inc. Dr Terahara and Mr Okawa, Mr Inakura, and Mr Hirayama are employees of Hisamitsu Pharmaceutical Co, Inc., (Copyright © 2023 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
47. [A Case of Autoimmune Acquired Factor XIII Deficiency Diagnosed from Recurrent Postoperative Bleeding].
- Author
-
Takashima Y, Kawanishi H, Kotani S, Watanabe H, Yokozeki H, Funahashi Y, Takaoka N, Fujiwara M, and Okumura K
- Subjects
- Male, Humans, Aged, Factor XIII therapeutic use, Hematoma etiology, Hematoma surgery, Factor XIII Deficiency complications, Factor XIII Deficiency diagnosis
- Abstract
The patient was a 79-year-old man with ureteroileal anastomotic stricture after a Bricker ileal conduit. Endourological treatment of stenosis was performed via percutaneous nephrostomy and ileal conduit. The patient experienced lower abdominal pain on the following day, and computed tomographic (CT) scan showed hematoma retention around the kidney and active bleeding from the renal artery branches. Transarterial embolisation (TAE) was performed and the bleeding was controlled. Two days later, there was a sudden progression of anemia and CT showed an increase in hematoma around the kidney. We subsequently performed nephrectomy for hemostasis. Five days later, the anemia progressed further. There was hematoma retention in the retroperitoneal cavity, and emergency laparotomy hemostasis was performed. Routine coagulation test results were normal. Heavy bleeding was observed several days after TAE and the possibility of coagulation factor XIII deficiency was considered. Factor XIII deficiency was confirmed by a low factor XIII activity level. The patient was given plasma-derived factor XIII. After receiving factor XIII replacement, factor XIII activity remained unchanged and the patient continued to bleed. Thereafter, a cross-mixing test was performed and the patient was diagnosed with autoimmune acquired factor XIII deficiency. Cortical steroids were administered to remove the factor XIII inhibitor. Steroid administration showed a rapid increase in factor XIII activity, and bleeding symptoms were no longer observed. In cases of serious bleeding of unknown cause with a normal coagulation profile, acquired factor XIII deficiency should be suspected and factor XIII activity measured.
- Published
- 2023
- Full Text
- View/download PDF
48. IL-31-generating network in atopic dermatitis comprising macrophages, basophils, thymic stromal lymphopoietin, and periostin.
- Author
-
Hashimoto T, Yokozeki H, Karasuyama H, and Satoh T
- Subjects
- Humans, Animals, Mice, Basophils, Cytokines, Macrophages metabolism, Pruritus metabolism, Thymic Stromal Lymphopoietin, Dermatitis, Atopic
- Abstract
Background: IL-31 is a type 2 cytokine involved in the itch sensation in atopic dermatitis (AD). The cellular origins of IL-31 are generally considered to be T
H 2 cells. Macrophages have also been implicated as cellular sources of IL-31., Objective: We sought to determine the expression of IL-31 by macrophages and to elucidate the productive mechanisms and contributions to itch in AD skin lesions., Methods: Expression of IL-31 by macrophages, expressions of thymic stromal lymphopoietin (TSLP) and periostin, and presence of infiltrating basophils in human AD lesions were examined through immunofluorescent staining, and correlations were assessed. Furthermore, mechanisms of inducing IL-31-expressing macrophages were analyzed in an MC903-induced murine model for AD in vivo and in mouse peritoneal macrophages ex vivo., Results: A significant population of IL-31+ cells in human AD lesions was that of CD68+ cells expressing CD163, an M2 macrophage marker. The number of IL-31+ /CD68+ cells correlated with epidermal TSLP, dermal periostin, and the number of dermal-infiltrating basophils. In the MC903-induced murine AD model, significant scratching behaviors with enhanced expressions of TSLP and periostin were observed, accompanied by massive infiltration of basophils and IL-31+ /MOMA-2+ /Arg-1+ cells. Blockade of IL-31 signaling with anti-IL-31RA antibody or direct depletion of macrophages by clodronate resulted in attenuation of scratching behaviors. To effectively reduce lesional IL-31+ macrophages and itch, basophil depletion was essential in combination with TSLP- and periostin-signal blocking. Murine peritoneal macrophages produced IL-31 when stimulated with TSLP, periostin, and basophils., Conclusions: A network comprising IL-31-expressing macrophages, TSLP, periostin, and basophils plays a significant role in AD itch., (Copyright © 2022 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
49. Cohort study of subclinical sensitization against galactose-α-1,3-galactose in Japan: Prevalence and regional variations.
- Author
-
Nakagawa Y, Chinuki Y, Ogino R, Yamasaki K, Aiba S, Ugajin T, Yokozeki H, Kitamura K, and Morita E
- Subjects
- Male, Cattle, Animals, Humans, Galactose, Prevalence, Cetuximab adverse effects, Cohort Studies, Japan epidemiology, Immunoglobulin E, Allergens, Epitopes, Tick Bites, Food Hypersensitivity epidemiology, Food Hypersensitivity diagnosis
- Abstract
Sensitization to galactose-α-1,3-galactose (α-Gal) leads to the development of α-Gal syndrome, which includes red meat allergy and cetuximab-induced anaphylaxis. Since tick bites represent the main cause of α-Gal sensitization, it was speculated that sensitization to α-Gal occurs throughout Japan. However, few cohort studies have investigated α-Gal sensitization in Japan. Therefore, we aimed to elucidate the subclinical sensitization rate to α-Gal in Japan. Sera were obtained from 300 participants without food or cetuximab allergy at Shimane University Hospital (Shimane prefecture), Tokyo Medical and Dental University Hospital (Tokyo metropolis), and Tohoku University Hospital (Miyagi prefecture). ImmunoCAP-bovine thyroglobulin (BTG), ImmunoCAP-beef, and IgE immunoblotting with cetuximab were performed to detect α-Gal-specific IgE. Clinical information was collected from participants using a questionnaire. The overall positivity rate of ImmunoCAP-BTG was 4.0% without significant inter-institute differences, whereas that for ImmunoCAP-beef was 9.7% with a significant inter-institute difference. Tokyo Medical and Dental University Hospital (19.0%) had the highest positivity rate. The positivity rate based on cetuximab IgE immunoblotting was 2.7%, without any significant inter-institute differences. The overall positivity rate for both ImmunoCAP-BTG and cetuximab immunoblotting was 2.0%, with a significant inter-institute difference; 5.0% of Shimane University Hospital was the highest. Two cases showed sensitization against the non-α-Gal epitope of cetuximab. The overall positivity rate for both ImmunoCAP-beef and cetuximab immunoblotting was 1.3%, without significant inter-institute differences. Male sex was associated with positive beef-specific IgE. The prevalence of subclinical sensitization to α-Gal is estimated at 2.0%-4.0% in Japan and may be higher in rural areas, supporting an association between tick bites and α-Gal sensitization. In contrast, the prevalence of subclinical sensitization to beef is 9.7% in Japan and is highest in Tokyo Metropolis, suggesting the presence of another IgE-binding epitope apart from α-Gal and another sensitization route in the sensitization to beef IgE., (© 2022 Japanese Dermatological Association.)
- Published
- 2022
- Full Text
- View/download PDF
50. Leukemia cutis with chronic myelomonocytic leukemia presenting with a variety of skin lesions.
- Author
-
Wada S, Namiki T, Miura K, and Yokozeki H
- Subjects
- Humans, Skin pathology, Leukemia, Leukemia, Myelomonocytic, Chronic complications, Leukemia, Myelomonocytic, Chronic diagnosis, Leukemia, Myelomonocytic, Chronic pathology, Skin Diseases pathology, Skin Neoplasms complications, Skin Neoplasms diagnosis, Skin Neoplasms pathology
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.